Logo image of NOTV

INOTIV INC (NOTV) Stock Overview

USA - NASDAQ:NOTV - US45783Q1004 - Common Stock

1.4 USD
+0.05 (+3.7%)
Last: 10/24/2025, 8:00:01 PM
1.42 USD
+0.02 (+1.43%)
After Hours: 10/24/2025, 8:00:01 PM

NOTV Key Statistics, Chart & Performance

Key Statistics
Market Cap48.09M
Revenue(TTM)505.30M
Net Income(TTM)-78964000
Shares34.35M
Float29.77M
52 Week High6.48
52 Week Low1.15
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.7
PEN/A
Fwd PEN/A
Earnings (Next)12-01 2025-12-01/amc
IPO1997-11-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


NOTV short term performance overview.The bars show the price performance of NOTV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

NOTV long term performance overview.The bars show the price performance of NOTV in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NOTV is 1.4 USD. In the past month the price increased by 1.45%. In the past year, price decreased by -18.13%.

INOTIV INC / NOTV Daily stock chart

NOTV Latest News, Press Relases and Analysis

NOTV Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.56 216.18B
DHR DANAHER CORP 28.92 159.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 148.65 48.49B
A AGILENT TECHNOLOGIES INC 27.16 41.97B
IQV IQVIA HOLDINGS INC 19.23 37.49B
MTD METTLER-TOLEDO INTERNATIONAL 35.07 29.55B
WAT WATERS CORP 29.39 21.40B
WST WEST PHARMACEUTICAL SERVICES 42.07 21.39B
MEDP MEDPACE HOLDINGS INC 42.32 17.00B
TEM TEMPUS AI INC N/A 15.50B
ILMN ILLUMINA INC 24.06 15.39B
ICLR ICON PLC 13.5 13.85B

About NOTV

Company Profile

NOTV logo image Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Company Info

INOTIV INC

2701 Kent Ave

West Lafayette INDIANA 47906 US

CEO: Robert W. Leasure Jr.

Employees: 2026

NOTV Company Website

NOTV Investor Relations

Phone: 13174634527

INOTIV INC / NOTV FAQ

Can you describe the business of INOTIV INC?

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.


Can you provide the latest stock price for INOTIV INC?

The current stock price of NOTV is 1.4 USD. The price increased by 3.7% in the last trading session.


Does NOTV stock pay dividends?

NOTV does not pay a dividend.


What is the ChartMill technical and fundamental rating of NOTV stock?

NOTV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is INOTIV INC (NOTV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NOTV.


What is INOTIV INC worth?

INOTIV INC (NOTV) has a market capitalization of 48.09M USD. This makes NOTV a Nano Cap stock.


What is the ownership structure of INOTIV INC (NOTV)?

You can find the ownership structure of INOTIV INC (NOTV) on the Ownership tab.


NOTV Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NOTV. When comparing the yearly performance of all stocks, NOTV is a bad performer in the overall market: 91.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NOTV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NOTV. Both the profitability and financial health of NOTV have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NOTV Financial Highlights

Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.7. The EPS increased by 29.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -10.39%
ROE -54.92%
Debt/Equity 2.73
Chartmill High Growth Momentum
EPS Q2Q%49%
Sales Q2Q%23.54%
EPS 1Y (TTM)29.69%
Revenue 1Y (TTM)0.85%

NOTV Forecast & Estimates

9 analysts have analysed NOTV and the average price target is 5.61 USD. This implies a price increase of 300.71% is expected in the next year compared to the current price of 1.4.

For the next year, analysts expect an EPS growth of 43.04% and a revenue growth 6.5% for NOTV


Analysts
Analysts80
Price Target5.61 (300.71%)
EPS Next Y43.04%
Revenue Next Year6.5%

NOTV Ownership

Ownership
Inst Owners25.37%
Ins Owners9.67%
Short Float %6.89%
Short Ratio5.56